FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism
This news release was updated to reflect the correct number of special controls that were established for this category of device. Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andMe Personal Genome …